Opportunity
Federal Register #Docket No. 50-608
NRC License Transfer Approval for SHINE Medical Isotope Production Facility
Buyer
Nuclear Regulatory Commission
Posted
April 30, 2026
Identifier
Docket No. 50-608
This notice concerns the regulatory approval of a license transfer for a medical isotope production facility: - Government Buyer: - U.S. Nuclear Regulatory Commission (NRC) - Action Details: - NRC approved the transfer of Construction Permit No. CPMIF-001 for the SHINE Medical Isotope Production Facility - Transfer is from SHINE Technologies, LLC to SHINE Chrysalis, LLC - Includes a conforming license amendment - Approves indirect transfer of control due to the creation of SHINE Chrysalis Holdings, LLC as the new parent company - Facility Location: - SHINE Medical Isotope Production Facility in Rock County, Wisconsin - No procurement of products or services is involved in this action - No OEMs, vendors, products, part numbers, or purchase quantities are requested or mentioned - The notice is regulatory and not a solicitation for goods or services
Description
The U.S. Nuclear Regulatory Commission (NRC) is issuing an order approving the license transfer application filed by SHINE Technologies, LLC. The order approves the direct transfer of Construction Permit No. CPMIF-001 for the SHINE Medical Isotope Production Facility from SHINE Technologies, LLC to SHINE Chrysalis, LLC and a conforming license amendment. It also approves the indirect transfer of control of the construction permit due to the establishment of SHINE Chrysalis Holdings, LLC as the direct parent company of SHINE Chrysalis, LLC. The order is effective for one year from April 22, 2026.